Windlas Biotech Share Price

Windlas Biotech Share Price

NSE: WINDLAS
|
Pharmaceuticals
|
S Cap
₹ 1,074.05
-₹28.25 (-2.56%)
1D
Last updated 23 Sep, 2026, 15:29 IST

Windlas Biotech Share Price Today

As of 24 Sep 2026, Windlas Biotech share price is ₹1,074.05. The stock opened at ₹1,105.00, compared to its previous close of ₹1,102.30. During today's trading session, Windlas Biotech share price moved in the range of ₹1,070.00 to ₹1,107.65, with an average price of ₹1,088.83 for the day. Looking at its last 52-week, the stock has touched a low of ₹697.40 and a high of ₹1,181.90. On the performance front, Windlas Biotech share price has increased by 47.74% over the last six months and is up 14.45% on a year-on-year basis.

₹1,070.00
2.56% down today
₹1,107.65
1D LOW
1D HIGH

Windlas Biotech Returns Calculator

Circuit
L
H
₹881.85
₹1,322.75
52-week
L
H
₹697.40
₹1,181.90

About Windlas Biotech

Windlas Biotech Share Price
ISIN
INE0H5O01029
Sector Market Cap
₹ 2,274.83 Cr

Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.

Windlas Biotech Financial Highlights

  • Revenue: Windlas Biotech reported revenue of ₹921.89 crore in FY26 vs ₹777.90 crore in FY25. It showed an increase of 18.51% on a yearly basis.
  • Operating Profit: Windlas Biotech reported an operating profit of ₹86.98 crore in FY26 vs ₹79.76 crore in FY25. It showed an increase of 9.05% on a year-on-year basis.
  • Net Profit: Windlas Biotech reported a net profit of ₹66.46 crore in FY26 vs ₹60.99 crore in FY25. It showed an increase of 8.97% on a yearly basis.

Windlas Biotech Quarterly Result Highlights

  • Windlas Biotech reported revenue of ₹242.85 crore in Mar 2026, compared with ₹237.67 crore in Dec 2025, representing an increase of 2.18% on a quarter-on-quarter (QoQ) basis.
  • Windlas Biotech reported an operating profit of ₹20.16 crore in Mar 2026, compared with ₹19.97 crore in Dec 2025, representing an increase of 0.95% on a quarter-on-quarter (QoQ) basis.
  • Windlas Biotech reported a profit of ₹15.99 crore in Mar 2026, compared with ₹15.00 crore in Dec 2025, reflecting an increase of 6.60% on a QoQ basis.
  • The earnings per share (EPS) of Windlas Biotech stood at ₹31.60 during Mar 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
63.31%
FII
2.04%
Other DII
4.09%
Retail and other
24.80%
Mutual funds
5.76%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.93%
Mar 20260.60%
May 20260.99%
Jun 20262.04%
Mkt Cap Cr
2,274.83
P/E
23.42
P/B
2.68
ROE
12.23%
D/E
0.06
ROCE
15.82%
Div. Yield
0.57%
EPS(TTM)
31.59
Turnover
1.04
EV/EBITDA
12.98
Net Margin
7.35%
Op. Margin
13.55%
ROA
10.73%
Quick Ratio
1.76
Curr. Ratio
2.18
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Windlas Biotech outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Windlas Biotech appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Windlas Biotech revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Windlas Biotech Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹904.09₹759.88₹630.96₹513.08
Other Income₹17.80₹18.02₹13.47₹9.97
Total Revenue₹921.89₹777.90₹644.42₹523.05
Total Expenses₹834.92₹698.14₹567.33₹466.01
Profit Before Tax₹86.98₹79.76₹77.09₹57.04
Tax₹20.52₹18.76₹18.90₹14.41
Profit After Tax₹66.46₹60.99₹58.19₹42.63
EPS - Basic₹31.60₹29.19₹27.97₹19.70
EPS - Diluted₹31.15₹28.87₹27.88₹19.70

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹86.98₹79.76₹77.09₹57.04
Income before WC changes₹123.72₹98.16₹83.66₹64.36
Change in Assets-₹66.36-₹57.64-₹5.52-₹25.36
Change in Liabilities₹62.73₹48.54₹49.47₹31.68
Change in WC-₹3.63-₹9.09₹43.95₹6.32
Cash flow from Operations₹104.93₹68.19₹108.96₹60.97
Cash flow from Investing-₹91.79-₹74.06-₹92.07-₹14.11
Cash flow from Financing-₹13.03₹1.01-₹15.29-₹43.74
Total Cash Flow₹0.11-₹4.86₹1.60₹3.12
Cash (Start of the year)₹0.42₹5.29₹3.69₹0.57
Cash (End of the year)₹0.54₹0.42₹5.29₹3.69

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹280.50₹235.02₹194.92₹175.44
Current Assets₹626.85₹525.43₹431.29₹353.54
Total Assets₹907.35₹760.45₹626.21₹528.98
Current Liabilities₹320.93₹249.44₹171.75₹121.24
Net Current Asset₹305.92₹275.98₹259.54₹232.29
Non-Current Liabilities₹5.58₹5.24₹4.52₹5.46
Equity Capital₹580.84₹505.77₹449.94₹402.27
Total Equity & Liabilities₹907.35₹760.45₹626.21₹528.98

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹904.09₹759.88₹630.96₹513.08
Other Income₹17.80₹17.65₹13.47₹9.97
Total Revenue₹921.89₹777.52₹644.42₹523.05
Total Expenses₹834.96₹698.13₹567.40₹465.99
Profit Before Tax₹86.93₹79.39₹77.02₹57.06
Tax₹20.50₹18.75₹18.88₹14.41
Profit After Tax₹66.44₹60.65₹58.14₹42.64
EPS - Basic₹31.59₹29.03₹27.95₹19.71
EPS - Diluted₹31.14₹28.71₹27.86₹19.71

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹86.93₹79.39₹77.02₹57.06
Income before WC changes₹123.67₹97.81₹83.62₹64.40
Change in Assets-₹66.36-₹57.64-₹5.52-₹25.36
Change in Liabilities₹62.74₹48.93₹49.43₹31.66
Change in WC-₹3.61-₹8.71₹43.91₹6.29
Cash flow from Operations₹104.93₹68.23₹108.91₹60.98
Cash flow from Investing-₹91.79-₹74.06-₹92.07-₹14.11
Cash flow from Financing-₹13.03₹1.01-₹15.29-₹43.74
Total Cash Flow₹0.11-₹4.82₹1.56₹3.13
Cash (Start of the year)₹0.42₹5.24₹3.69₹0.55
Cash (End of the year)₹0.53₹0.42₹5.24₹3.69

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹280.50₹235.32₹194.92₹175.47
Current Assets₹626.84₹525.13₹431.24₹353.54
Total Assets₹907.34₹760.45₹626.16₹529.01
Current Liabilities₹320.93₹249.42₹171.35₹120.88
Net Current Asset₹305.92₹275.70₹259.89₹232.65
Non-Current Liabilities₹5.58₹5.24₹4.52₹5.46
Equity Capital₹580.83₹505.79₹450.29₹402.67
Total Equity & Liabilities₹907.34₹760.45₹626.16₹529.01
* All values are in INR Crore
Qty
Bid
10
1077.45
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 10
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.36
Neutral
ATR (14)
45.53
Neutral
STOCH(9,6)
21.89
Neutral
STOCH RSI (14)
0
Bullish
ADX(9)
28.77
Bearish
UO(9)
43.35
Neutral
ROC(12)
-4.64
Bearish
WillR(14)
-82.27
Bullish
Period
Simple value
Exponential vaue
5D
1106.56
1098.83
10D
1110.71
1100.65
20D
1086.23
1076.92
50D
971.68
1000.43
100D
898.02
932.84
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep1L
18 Sep0L
17 Sep1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Windlas Biotech Share Price
Windlas Biotech
Pharmaceuticals
Add Stock
Add Another

Windlas Biotech Share Price FAQs

Windlas Biotech share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837